In This Issue:
In this issue:
,
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
In this issue: President’s Corner, An Artist’s Journey with Macular Degeneration: Wyncia’s Story, Does Aspirin Increase the Risk of Permanent Vision Loss from Macular Degeneration? And more!
A BrightFocus Foundation Macular Degeneration Research grant recipient aims to bridge the gap in available testing for AMD and detect the condition as early as possible.
Increased eye inflammation with age may contribute to macular degeneration and present differently between sexes, suggests a new BrightFocus-funded study.
Discover research led by BrightFocus Foundation Macular Degeneration Research grant recipient, Dr. Albert Gonzales on how enhancing blood flow to the eye could lead to new treatments for macular degeneration.
BrightFocus President and CEO Stacy Pagos Haller spoke with WebMD's Chief Medical Officer John Whyte, MD, MPH, as part of its “Champions for Change” series to discuss the progress being made to advance the understanding of geographic atrophy, which affects around 1 million people in the U.S.
